Platelet Glycoprotein Iib/Iiia Inhibitors in Cardiovascular Disease

Lincoff, A. Michael, M.D. (EDT)

ISBN 10: 1588291855 ISBN 13: 9781588291851
Edité par Humana, 2003
Neuf(s) Couverture rigide

Vendeur GreatBookPrices, Columbia, MD, Etats-Unis Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Vendeur AbeBooks depuis 6 avril 2009


A propos de cet article

Description :

N° de réf. du vendeur 1202186-n

Signaler cet article

Synopsis :

One of the most important developments in the field of cardiovascular medicine over the last two decades has been recognition of the key role played by arterial thrombosis in the pathogenesis of acute coronary syndromes, ischemic complications of percutane- ous coronary revascularization, and coronary and peripheral atherosclerosis. The phar- macologic armamentarium directed against vascular thrombosis has thus expanded substantially during that time, with development of new fibrinolytic agents, low-molecu- lar-weight heparins, direct thrombin inhibitors, antagonists to platelet activation, and the platelet glycoprotein lIb/IlIa inhibitors. Though clinical investigations of these com- pounds have been marked by failures as well as successes, there is little doubt that enhanced antithrombotic therapies have markedly improved the outcome of patients undergoing coronary revascularization or with acute coronary syndromes. Glycoprotein IIblIlIa receptor antagonists were introduced into clinical practice to overcome the limitations of approaches that inhibit only individual pathways of platelet activation. Multiple mechanisms of platelet activation in response to different agonists converge on the platelet membrane glycoprotein IIblIlIa complex, the "final common pathway" of platelet aggregation. The clinical hemorrhagic syndrome caused by a rare inherited defect in this receptor (Glanzmann' s thrombasthenia), characterized by muco- cutaneous and postsurgical bleeding, but infrequent spontaneous organ (particularly central nervous system) bleeding, suggested that therapeutic inhibition of this receptor might be a potent, yet well-tolerated means of treating thrombotic disorders.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Détails bibliographiques

Titre : Platelet Glycoprotein Iib/Iiia Inhibitors in...
Éditeur : Humana
Date d'édition : 2003
Reliure : Couverture rigide
Etat : New
Edition : 2ème Édition

Meilleurs résultats de recherche sur AbeBooks

There are 3 autres exemplaires de ce livre sont disponibles

Afficher tous les résultats pour ce livre